Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGC| |TGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTG
End
26727931/26727822 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/9571830; hsa-mir-103a-1/Downstream/5208280;
Upstream sequence
attttctttatccagtctatcattgatgggcattttgtttggttccaagtgtttgctattgtaaatagtgctgcaataaacatacatgtgcatgtgtctt
Downstream sequence
AGTAAAGACCGTAGTAAAGCACAAGGTAAGGTGGACATTGTTAAGGAAAGTGATAAGGTGGTTAGAAACTGTTTTTTCTCAACCACAAAGCACTTGCATA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.